Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-1-6
pubmed:abstractText
Pancreatic ductal adenocarcinomas (PDACs) overexpress several members of the fibroblast growth factor (FGF) family of ligands and the type I FGF receptor (FGFR-1), and enhanced FGF-2 protein levels correlate with shorter postoperative survival of patients with PDAC. In this study, we investigated the effects of FGF-2 on cell proliferation and mitogen-activated protein kinase (MAPK) activation before and after abrogation of FGFR-1-dependent signaling in 4 pancreatic cancer cell lines (ASPC-1, COLO-357, MIA-PaCa-2, and PANC-1). Signaling was blocked by infecting the cells with an adenoviral vector encoding for a truncated FGFR-1 (AdtrFGFR-1). FGF-2 enhanced the growth of all 4 cell lines and activated MAPK in 3 of these cell lines. Infection with the AdtrFGFR-1 virus resulted in abundant expression of the truncated FGFR-1 at the RNA and protein level, markedly attenuated FGF-2-induced proliferation in all 4 tested cell lines, and decreased FGF-2-dependent MAPK activation in the 3 cell lines in which FGF-2 activated this pathway. These findings suggest that FGFR-1-mediated mitogenesis in multiple pancreatic cancer cells can be efficiently blocked with an adenoviral vector encoding a truncated FGFR-1, raising the possibility that AdtrFGFR-1 may ultimately have a therapeutic role in PDAC.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1536-4828
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
28
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
25-30
pubmed:dateRevised
2010-5-26
pubmed:meshHeading
pubmed-meshheading:14707726-Adenoviridae, pubmed-meshheading:14707726-Cell Division, pubmed-meshheading:14707726-Cell Line, pubmed-meshheading:14707726-Cell Line, Tumor, pubmed-meshheading:14707726-Dose-Response Relationship, Drug, pubmed-meshheading:14707726-Enzyme Activation, pubmed-meshheading:14707726-Fibroblast Growth Factor 2, pubmed-meshheading:14707726-Gene Expression, pubmed-meshheading:14707726-Humans, pubmed-meshheading:14707726-Mitogen-Activated Protein Kinases, pubmed-meshheading:14707726-Mutation, pubmed-meshheading:14707726-Pancreatic Neoplasms, pubmed-meshheading:14707726-RNA, Messenger, pubmed-meshheading:14707726-Receptor, Fibroblast Growth Factor, Type 1, pubmed-meshheading:14707726-Receptor Protein-Tyrosine Kinases, pubmed-meshheading:14707726-Receptors, Fibroblast Growth Factor, pubmed-meshheading:14707726-Signal Transduction, pubmed-meshheading:14707726-Transfection
pubmed:year
2004
pubmed:articleTitle
Adenovirus-mediated transfer of a truncated fibroblast growth factor (FGF) type I receptor blocks FGF-2 signaling in multiple pancreatic cancer cell lines.
pubmed:affiliation
Division of Endocrinology, Department of Medicine, University of Heidelberg, Germany.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.